ReviewCell chemical biology2026
Chemical biology tools for studying histone post-translational modifications.
Review in Cell chemical biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Post-translational modifications (PTMs) of histones are central regulators of chromatin organization and gene expression, providing a dynamic and reversible mechanism to encode cellular state. While advances in mass spectrometry have rapidly expanded the catalog of histone PTMs beyond classical acetylation and methylation, defining their functional roles remains a major challenge. A central bottleneck is linking specific PTMs to the enzymes that write and erase them, as well as the reader proteins that interpret them within native chromatin environments. The dysregulation of this regulatory machinery is increasingly implicated in cancer, neurodevelopmental disorders, and metabolic disease. Here, we argue that resolving PTM function requires integrating chemical precision with increasing biological complexity. We review chemical biology strategies for interrogating histone PTMs across this spectrum-from synthetic peptides to semisynthetic nucleosomes and intact chromatin-highlighting how each approach balances experimental control with physiological relevance and propose future directions for systematically mapping PTM-dependent interactions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.